The Zika virus may be associated with an autoimmune disorder that attacks the brain's myelin similar to multiple sclerosis, according to a small study that is being released today and will be presented at the American Academy of Neurology's 68th annual meeting in Vancouver, Canada, April 15-21, 2016.
"Though our study is small, it may provide evidence that in this case the virus has different effects on the brain than those identified in current studies," said study author Maria Lucia Brito Ferreira, MD, with Restoration Hospital in Recife, Brazil. "Much more research will need to be done to explore whether there is a causal link between Zika and these brain problems."
For the study, researchers followed people who came to the hospital in Recife from December 2014 to June 2015 with symptoms compatible with arboviruses, the family of viruses that includes Zika, dengue and chikungunya. Six people then developed neurologic symptoms that were consistent with autoimmune disorders and underwent exams and blood tests. The authors saw 151 cases with neurological manifestations during a period of December 2014 to December 2015.
All of the people came to the hospital with fever followed by a rash. Some also had severe itching, muscle and joint pain and red eyes. The neurologic symptoms started right away for some people and up to 15 days later for others.
Of the six people who had neurologic problems, two of the people developed acute disseminated encephalomyelitis (ADEM), an attack of swelling of the brain and spinal cord that attacks the myelin, which is the coating around nerve fibers. In both cases, brain scans showed signs of damage to the brain's white matter. Unlike MS, acute disseminated encephalomyelitis usually consists of a single attack that most people recover from within six months. In some cases, the disease can reoccur. Four of the people developed Guillain-Barré syndrome (GBS), a syndrome that involves myelin of the peripheral nervous system and has a previously reported association with the Zika virus.
When they were discharged from the hospital, five of the six people still had problems with motor functioning. One person had vision problems and one had problems with memory and thinking skills.
Tests showed that the participants all had Zika virus. Tests for dengue and chikungunya were negative.
"This doesn't mean that all people infected with Zika will experience these brain problems. Of those who have nervous system problems, most do not have brain symptoms," said Ferreira. "However, our study may shed light on possible lingering effects the virus may be associated with in the brain."
"At present, it does not seem that ADEM cases are occurring at a similarly high incidence as the GBS cases, but these findings from Brazil suggest that clinicians should be vigilant for the possible occurrence of ADEM and other immune-mediated illnesses of the central nervous system," said James Sejvar, MD, with the Centers for Disease Control and Prevention in Atlanta and a member of the American Academy of Neurology. "Of course, the remaining question is 'why'-why does Zika virus appear to have this strong association with GBS and potentially other immune/inflammatory diseases of the nervous system? Hopefully, ongoing investigations of Zika virus and immune-mediated neurologic disease will shed additional light on this important question."
Source: American Academy of Neurology
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
The Clean Bite: Real Talk About Infection Control — From the Classroom to the Operatory
August 5th 2025Want dental assistants who don’t just know infection control, but live it from day one? Tune in to The Clean Bite and learn how powerhouse instructor Samantha Mangioni is shaping the next generation to protect every patient, every time.
Fuel Immunity First: How to Use Nutrition to Stay Ahead of Infection
August 5th 2025Infection prevention starts long before exposure; it begins with what we put into our bodies. This article series explores how key vitamins and nutrients like D, C, zinc, and more can strengthen immune defenses, reduce respiratory illness severity, and empower infection preventionists with evidence-based strategies to support overall health from the inside out.
Rethinking Clean: How Outdated Disinfection Practices Are Fueling the AMR Crisis
August 5th 2025As drug-resistant infections rise, infection preventionists must look beyond outdated disinfectants. HOCl offers a safer, sustainable solution that has been proven effective, residue-free, and ready for health care use today.
Sharps Safety Starts with Us: Why Infection Preventionists Must Lead the Charge
August 5th 2025Sharps injuries remain a silent but serious threat in health care that infection preventionists are uniquely equipped to confront. With underreporting widespread and safety devices underused, it’s time for IPs to step into a leadership role, using their expertise in systems thinking, education, and policy to build a culture where staff protection is as prioritized as patient care.
Is the US Quietly Ending COVID-19 Vaccination for the Young and Healthy
August 5th 2025As the FDA limits COVID-19 vaccine approvals to high-risk groups, healthy adults and pregnant individuals are being left behind. Learn how these changes could impact insurance coverage, long COVID prevention, and public health strategies.